Patterson Companies Board Approves New Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend
Patterson Companies Board Approves New Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend
On March 11, 2024, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) approved a new share repurchase authorization for the repurchase of up to $500 million of the company’s common stock through March 16, 2027, replacing a prior authorization which was expiring and under which there was $194.9 million remaining.
The Board also declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, May 3, 2024, to shareholders of record as of the close of business on April 19, 2024.
About Patterson Companies Inc.
Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support.
Learn more: pattersoncompanies.com
John M. Wright, Investor Relations
COMPANY: Patterson Companies Inc.
EMAIL: investor.relations@pattersoncompanies.com
WEB: pattersoncompanies.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240311880553/en/
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?